Abstract
Diterpenoids jolkinolide A and B, were first isolated from Euphorbia fischeriana. In our previous research, 19-(Benzyloxy)-19-oxojolkinolide B (19-BJB), a derivative of jolkinolides, was synthesized as a novel ent -abietane diterpene diepoxide. In this study, 19-BJB showed strong in vitro activity against bladder cancer cell lines. DNA damage which was observed through the interaction of 19-BJB with nucleotide chains and affected DNA repair resulted in the activation of checkpoint kinase 1 (Chk1) and checkpoint kinase 2 (Chk2) in bladder cancer cell lines. In vivo testing in nude mice also proved that 19-BJB revealed a potential inhibitory effect on tumor growth. Additionally, the 3D-QSAR models of jolkinolides were established. Briefly, we proved that 19-BJB could potentially be used as a drug to inhibit the growth of bladder tumor.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Abietanes / pharmacology*
-
Abietanes / therapeutic use
-
Animals
-
Antineoplastic Agents, Phytogenic
-
Cell Line, Tumor
-
Checkpoint Kinase 1 / metabolism
-
Checkpoint Kinase 2 / metabolism
-
DNA Damage / drug effects*
-
DNA Repair
-
Diterpenes / pharmacology*
-
Diterpenes / therapeutic use
-
Drugs, Chinese Herbal / pharmacology*
-
Drugs, Chinese Herbal / therapeutic use
-
Euphorbia / chemistry
-
Humans
-
Male
-
Mice
-
Molecular Docking Simulation
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / pathology
-
Xenograft Model Antitumor Assays
Substances
-
Abietanes
-
Antineoplastic Agents, Phytogenic
-
Diterpenes
-
Drugs, Chinese Herbal
-
Checkpoint Kinase 2
-
CHEK1 protein, human
-
CHEK2 protein, human
-
Checkpoint Kinase 1
Grants and funding
This research was funded by the National Natural Science Foundation of China (No. 30973607; No. 81172934); Ministry of Science and Technology of Taiwan (MOST 103-2911-I-002-303; MOST 104-2911-I-002-302; MOST 107-2320-B-037-001), National Health Research Institutes of Taiwan (NHRI-EX104-10241BI).